Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.13NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
HK.13NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-18427.7US
GK.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
GK.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
FL.24.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.24.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
FL.24.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
GK.1.8.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1.8.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
GK.1.8.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
GE.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GE.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
GE.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
EG.5.1.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.7NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
EG.5.1.7NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
GA.4.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.4.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
GA.4.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21062.3US
HK.3.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.3.2.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
HK.3.2.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
HK.13.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.13.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
HK.13.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
FL.20.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.20.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
FL.20.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
HK.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
HK.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
HK.8.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.8.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
HK.8.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XBB.1.19.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.19.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
XBB.1.19.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
GE.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GE.1.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
GE.1.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
EG.6.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.6.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
EG.6.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
FU.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FU.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
FU.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
DV.7.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DV.7.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used